>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
April 15, 2014
Medicure Comments on Recent Trading Activity Read more
April 14, 2014
Medicure Engages Knight Therapeutics Inc.to Provide Advisory Services Read more
March 26, 2014
MEDICURE REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER FISCAL 2014 Read more
Sign up to receive email updates such as Press Release nofications and other company news.